SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.810.0%Nov 24 3:58 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (4966)12/1/1997 9:35:00 PM
From: Robert K.  Read Replies (3) of 17367
 
Good work there opalapril. Lets hear the results of your e-mail.
FYI-xoma glossary is complete pending "overview". Some other updates almost ready too. Faq will have to wait a wee bit more.
Thank goodness for the difference between lbp(rotien) and lbp(eptide). I think lbp (protien) has a lot to offer regarding xomas future, but thats premature speculation on my part. Also xoma cash is probably down to 25-30mil, we should see either gne money soon,financing, a deal or any combination in the not too distant future.
Oh, almost forgot, angiogenesis product is not high priority at this time
(resourses are on bpi21) however that could change with a deal.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext